Literature DB >> 23129740

Possible role for tocilizumab, an anti-interleukin-6 receptor antibody, in treating cancer cachexia.

Katsutoshi Ando1, Fumiyuki Takahashi, Shinji Motojima, Kei Nakashima, Norihiro Kaneko, Kazuei Hoshi, Kazuhisa Takahashi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23129740     DOI： 10.1200/JCO.2012.44.2020

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  44 in total

1.  Emerging new therapeutic alternatives for the management of cancer cachexia: recent insights.

Authors:  Shailendra Kapoor
Journal:  Support Care Cancer       Date:  2013-04-25       Impact factor: 3.603

Review 2.  Role of interleukin-6 in cachexia: therapeutic implications.

Authors:  Aditi A Narsale; James A Carson
Journal:  Curr Opin Support Palliat Care       Date:  2014-12       Impact factor: 2.302

3.  Blockade of the IL-6 trans-signalling/STAT3 axis suppresses cachexia in Kras-induced lung adenocarcinoma.

Authors:  A Miller; L McLeod; S Alhayyani; A Szczepny; D N Watkins; W Chen; P Enriori; W Ferlin; S Ruwanpura; B J Jenkins
Journal:  Oncogene       Date:  2016-11-28       Impact factor: 9.867

4.  Role of IL-6 in Mycobacterium avium--associated immune reconstitution inflammatory syndrome.

Authors:  Daniel L Barber; Bruno B Andrade; Cortez McBerry; Irini Sereti; Alan Sher
Journal:  J Immunol       Date:  2013-12-11       Impact factor: 5.422

Review 5.  [Influence of therapy on risk of cancer in rheumatoid arthritis. Pathophysiological principles].

Authors:  M J Waldner; A Strangfeld; M Aringer
Journal:  Z Rheumatol       Date:  2016-02       Impact factor: 1.372

6.  Interleukin-6 cytokine: a multifunctional glycoprotein for cancer.

Authors:  Paul Zarogoulidis; Lonny Yarmus; Kaid Darwiche; Robert Walter; Haidong Huang; Zhigang Li; Bojan Zaric; Kosmas Tsakiridis; Konstantinos Zarogoulidis
Journal:  Immunome Res       Date:  2013-08-12

7.  Sex differences in the relationship of IL-6 signaling to cancer cachexia progression.

Authors:  Kimbell L Hetzler; Justin P Hardee; Melissa J Puppa; Aditi A Narsale; Shuichi Sato; J Mark Davis; James A Carson
Journal:  Biochim Biophys Acta       Date:  2014-12-30

Review 8.  Pathobiological mechanisms underlying metabolic syndrome (MetS) in chronic obstructive pulmonary disease (COPD): clinical significance and therapeutic strategies.

Authors:  Stanley M H Chan; Stavros Selemidis; Steven Bozinovski; Ross Vlahos
Journal:  Pharmacol Ther       Date:  2019-02-26       Impact factor: 12.310

Review 9.  Process of hepatic metastasis from pancreatic cancer: biology with clinical significance.

Authors:  Haojun Shi; Ji Li; Deliang Fu
Journal:  J Cancer Res Clin Oncol       Date:  2015-08-07       Impact factor: 4.553

10.  Cancer-associated fibroblasts promote endometrial cancer growth via activation of interleukin-6/STAT-3/c-Myc pathway.

Authors:  Kavita S Subramaniam; Intan Sofia Omar; Soke Chee Kwong; Zahurin Mohamed; Yin Ling Woo; Noor Azmi Mat Adenan; Ivy Chung
Journal:  Am J Cancer Res       Date:  2016-01-15       Impact factor: 6.166
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.